nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—HTR3A—fourth ventricle—germ cell cancer	0.0802	0.283	CbGeAlD
Palonosetron—CYP3A4—Ifosfamide—germ cell cancer	0.0778	0.266	CbGbCtD
Palonosetron—CYP1A2—Etoposide—germ cell cancer	0.071	0.243	CbGbCtD
Palonosetron—CYP2D6—Vinblastine—germ cell cancer	0.0649	0.222	CbGbCtD
Palonosetron—HTR3A—myenteric nerve plexus—germ cell cancer	0.0562	0.198	CbGeAlD
Palonosetron—CYP3A4—Vinblastine—germ cell cancer	0.0413	0.141	CbGbCtD
Palonosetron—HTR3A—vagus nerve—germ cell cancer	0.0375	0.132	CbGeAlD
Palonosetron—CYP3A4—Etoposide—germ cell cancer	0.0372	0.127	CbGbCtD
Palonosetron—HTR3A—cranial nerve—germ cell cancer	0.0286	0.101	CbGeAlD
Palonosetron—HTR3A—ganglion—germ cell cancer	0.0145	0.051	CbGeAlD
Palonosetron—CYP1A2—urine—germ cell cancer	0.0109	0.0386	CbGeAlD
Palonosetron—CYP3A4—urine—germ cell cancer	0.00792	0.028	CbGeAlD
Palonosetron—CYP2D6—urine—germ cell cancer	0.0078	0.0275	CbGeAlD
Palonosetron—HTR3A—trigeminal ganglion—germ cell cancer	0.0071	0.0251	CbGeAlD
Palonosetron—HTR3A—brainstem—germ cell cancer	0.00628	0.0222	CbGeAlD
Palonosetron—HTR3A—telencephalon—germ cell cancer	0.00558	0.0197	CbGeAlD
Palonosetron—HTR3A—head—germ cell cancer	0.00347	0.0123	CbGeAlD
Palonosetron—HTR3A—brain—germ cell cancer	0.00252	0.00888	CbGeAlD
Palonosetron—CYP2D6—brainstem—germ cell cancer	0.00231	0.00815	CbGeAlD
Palonosetron—CYP2D6—telencephalon—germ cell cancer	0.00205	0.00724	CbGeAlD
Palonosetron—Convulsion—Vinblastine—germ cell cancer	0.00199	0.00468	CcSEcCtD
Palonosetron—Hypertension—Vinblastine—germ cell cancer	0.00198	0.00467	CcSEcCtD
Palonosetron—Hyperbilirubinaemia—Methotrexate—germ cell cancer	0.00197	0.00464	CcSEcCtD
Palonosetron—Alopecia—Bleomycin—germ cell cancer	0.00197	0.00463	CcSEcCtD
Palonosetron—Erythema—Bleomycin—germ cell cancer	0.00194	0.00456	CcSEcCtD
Palonosetron—Bradycardia—Ifosfamide—germ cell cancer	0.00194	0.00456	CcSEcCtD
Palonosetron—Discomfort—Vinblastine—germ cell cancer	0.00193	0.00455	CcSEcCtD
Palonosetron—Hepatic enzyme increased—Methotrexate—germ cell cancer	0.00189	0.00446	CcSEcCtD
Palonosetron—Urinary tract disorder—Ifosfamide—germ cell cancer	0.00188	0.00442	CcSEcCtD
Palonosetron—Connective tissue disorder—Ifosfamide—germ cell cancer	0.00187	0.0044	CcSEcCtD
Palonosetron—Urethral disorder—Ifosfamide—germ cell cancer	0.00186	0.00439	CcSEcCtD
Palonosetron—Chills—Dactinomycin—germ cell cancer	0.00186	0.00439	CcSEcCtD
Palonosetron—Alopecia—Dactinomycin—germ cell cancer	0.00183	0.00432	CcSEcCtD
Palonosetron—Respiratory failure—Methotrexate—germ cell cancer	0.00182	0.0043	CcSEcCtD
Palonosetron—CYP1A2—endocrine gland—germ cell cancer	0.00182	0.00641	CbGeAlD
Palonosetron—Erythema—Dactinomycin—germ cell cancer	0.00181	0.00426	CcSEcCtD
Palonosetron—Anaemia—Bleomycin—germ cell cancer	0.00179	0.00422	CcSEcCtD
Palonosetron—Anorexia—Vinblastine—germ cell cancer	0.00178	0.0042	CcSEcCtD
Palonosetron—Eye disorder—Ifosfamide—germ cell cancer	0.00178	0.00419	CcSEcCtD
Palonosetron—Tinnitus—Ifosfamide—germ cell cancer	0.00177	0.00418	CcSEcCtD
Palonosetron—Cardiac disorder—Ifosfamide—germ cell cancer	0.00177	0.00416	CcSEcCtD
Palonosetron—Hepatobiliary disease—Cisplatin—germ cell cancer	0.00173	0.00407	CcSEcCtD
Palonosetron—Angiopathy—Ifosfamide—germ cell cancer	0.00173	0.00407	CcSEcCtD
Palonosetron—Immune system disorder—Ifosfamide—germ cell cancer	0.00172	0.00405	CcSEcCtD
Palonosetron—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00171	0.00404	CcSEcCtD
Palonosetron—Chills—Ifosfamide—germ cell cancer	0.00171	0.00402	CcSEcCtD
Palonosetron—Arrhythmia—Ifosfamide—germ cell cancer	0.0017	0.004	CcSEcCtD
Palonosetron—Paraesthesia—Vinblastine—germ cell cancer	0.00168	0.00396	CcSEcCtD
Palonosetron—Alopecia—Ifosfamide—germ cell cancer	0.00168	0.00396	CcSEcCtD
Palonosetron—Anaemia—Dactinomycin—germ cell cancer	0.00167	0.00393	CcSEcCtD
Palonosetron—Bradycardia—Cisplatin—germ cell cancer	0.00167	0.00393	CcSEcCtD
Palonosetron—Mental disorder—Ifosfamide—germ cell cancer	0.00167	0.00393	CcSEcCtD
Palonosetron—Malnutrition—Ifosfamide—germ cell cancer	0.00166	0.0039	CcSEcCtD
Palonosetron—Erythema—Ifosfamide—germ cell cancer	0.00166	0.0039	CcSEcCtD
Palonosetron—Myalgia—Bleomycin—germ cell cancer	0.00165	0.00389	CcSEcCtD
Palonosetron—Discomfort—Bleomycin—germ cell cancer	0.00163	0.00384	CcSEcCtD
Palonosetron—Decreased appetite—Vinblastine—germ cell cancer	0.00163	0.00383	CcSEcCtD
Palonosetron—Urinary tract disorder—Cisplatin—germ cell cancer	0.00162	0.00381	CcSEcCtD
Palonosetron—Connective tissue disorder—Cisplatin—germ cell cancer	0.00161	0.0038	CcSEcCtD
Palonosetron—Urethral disorder—Cisplatin—germ cell cancer	0.00161	0.00379	CcSEcCtD
Palonosetron—Constipation—Vinblastine—germ cell cancer	0.0016	0.00377	CcSEcCtD
Palonosetron—Pain—Vinblastine—germ cell cancer	0.0016	0.00377	CcSEcCtD
Palonosetron—Hepatobiliary disease—Etoposide—germ cell cancer	0.00158	0.00373	CcSEcCtD
Palonosetron—Anaphylactic shock—Bleomycin—germ cell cancer	0.00158	0.00372	CcSEcCtD
Palonosetron—Infection—Bleomycin—germ cell cancer	0.00157	0.0037	CcSEcCtD
Palonosetron—Myalgia—Dactinomycin—germ cell cancer	0.00154	0.00362	CcSEcCtD
Palonosetron—Eye disorder—Cisplatin—germ cell cancer	0.00153	0.00361	CcSEcCtD
Palonosetron—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00153	0.00361	CcSEcCtD
Palonosetron—Anaemia—Ifosfamide—germ cell cancer	0.00153	0.0036	CcSEcCtD
Palonosetron—Tinnitus—Cisplatin—germ cell cancer	0.00153	0.0036	CcSEcCtD
Palonosetron—Cardiac disorder—Cisplatin—germ cell cancer	0.00152	0.00358	CcSEcCtD
Palonosetron—Discomfort—Dactinomycin—germ cell cancer	0.00152	0.00358	CcSEcCtD
Palonosetron—Anorexia—Bleomycin—germ cell cancer	0.00151	0.00355	CcSEcCtD
Palonosetron—Urinary tract disorder—Etoposide—germ cell cancer	0.00148	0.00349	CcSEcCtD
Palonosetron—Immune system disorder—Cisplatin—germ cell cancer	0.00148	0.00349	CcSEcCtD
Palonosetron—Abdominal pain—Vinblastine—germ cell cancer	0.00148	0.00349	CcSEcCtD
Palonosetron—Mediastinal disorder—Cisplatin—germ cell cancer	0.00148	0.00348	CcSEcCtD
Palonosetron—Hypotension—Bleomycin—germ cell cancer	0.00148	0.00348	CcSEcCtD
Palonosetron—Urethral disorder—Etoposide—germ cell cancer	0.00147	0.00347	CcSEcCtD
Palonosetron—Infection—Dactinomycin—germ cell cancer	0.00146	0.00345	CcSEcCtD
Palonosetron—Arrhythmia—Cisplatin—germ cell cancer	0.00146	0.00345	CcSEcCtD
Palonosetron—Alopecia—Cisplatin—germ cell cancer	0.00145	0.00341	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00144	0.00339	CcSEcCtD
Palonosetron—Convulsion—Ifosfamide—germ cell cancer	0.00143	0.00338	CcSEcCtD
Palonosetron—Hypertension—Ifosfamide—germ cell cancer	0.00143	0.00337	CcSEcCtD
Palonosetron—Erythema—Cisplatin—germ cell cancer	0.00143	0.00336	CcSEcCtD
Palonosetron—Malnutrition—Cisplatin—germ cell cancer	0.00143	0.00336	CcSEcCtD
Palonosetron—Paraesthesia—Bleomycin—germ cell cancer	0.00142	0.00334	CcSEcCtD
Palonosetron—Dyspnoea—Bleomycin—germ cell cancer	0.00141	0.00332	CcSEcCtD
Palonosetron—Myalgia—Ifosfamide—germ cell cancer	0.00141	0.00332	CcSEcCtD
Palonosetron—Arthralgia—Ifosfamide—germ cell cancer	0.00141	0.00332	CcSEcCtD
Palonosetron—Flatulence—Cisplatin—germ cell cancer	0.00141	0.00331	CcSEcCtD
Palonosetron—Anorexia—Dactinomycin—germ cell cancer	0.00141	0.00331	CcSEcCtD
Palonosetron—Eye disorder—Etoposide—germ cell cancer	0.0014	0.00331	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.0014	0.0033	CcSEcCtD
Palonosetron—Cardiac disorder—Etoposide—germ cell cancer	0.00139	0.00328	CcSEcCtD
Palonosetron—Discomfort—Ifosfamide—germ cell cancer	0.00139	0.00328	CcSEcCtD
Palonosetron—CYP2D6—female gonad—germ cell cancer	0.00139	0.00491	CbGeAlD
Palonosetron—Hypersensitivity—Vinblastine—germ cell cancer	0.00138	0.00325	CcSEcCtD
Palonosetron—Decreased appetite—Bleomycin—germ cell cancer	0.00137	0.00324	CcSEcCtD
Palonosetron—Angiopathy—Etoposide—germ cell cancer	0.00136	0.00321	CcSEcCtD
Palonosetron—Immune system disorder—Etoposide—germ cell cancer	0.00136	0.0032	CcSEcCtD
Palonosetron—Mediastinal disorder—Etoposide—germ cell cancer	0.00135	0.00319	CcSEcCtD
Palonosetron—Pain—Bleomycin—germ cell cancer	0.00135	0.00319	CcSEcCtD
Palonosetron—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00135	0.00318	CcSEcCtD
Palonosetron—Chills—Etoposide—germ cell cancer	0.00135	0.00318	CcSEcCtD
Palonosetron—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.00134	0.00317	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00134	0.00316	CcSEcCtD
Palonosetron—Asthenia—Vinblastine—germ cell cancer	0.00134	0.00316	CcSEcCtD
Palonosetron—Infection—Ifosfamide—germ cell cancer	0.00134	0.00316	CcSEcCtD
Palonosetron—Alopecia—Etoposide—germ cell cancer	0.00133	0.00313	CcSEcCtD
Palonosetron—Nervous system disorder—Ifosfamide—germ cell cancer	0.00133	0.00312	CcSEcCtD
Palonosetron—Anaemia—Cisplatin—germ cell cancer	0.00132	0.00311	CcSEcCtD
Palonosetron—CYP3A4—endocrine gland—germ cell cancer	0.00131	0.00464	CbGeAlD
Palonosetron—Skin disorder—Ifosfamide—germ cell cancer	0.00131	0.00309	CcSEcCtD
Palonosetron—CYP2D6—endocrine gland—germ cell cancer	0.00129	0.00456	CbGeAlD
Palonosetron—Anorexia—Ifosfamide—germ cell cancer	0.00129	0.00303	CcSEcCtD
Palonosetron—Decreased appetite—Dactinomycin—germ cell cancer	0.00128	0.00302	CcSEcCtD
Palonosetron—Diarrhoea—Vinblastine—germ cell cancer	0.00128	0.00302	CcSEcCtD
Palonosetron—Dysgeusia—Etoposide—germ cell cancer	0.00128	0.00302	CcSEcCtD
Palonosetron—CYP2D6—head—germ cell cancer	0.00128	0.00451	CbGeAlD
Palonosetron—Fatigue—Dactinomycin—germ cell cancer	0.00127	0.00299	CcSEcCtD
Palonosetron—Hypotension—Ifosfamide—germ cell cancer	0.00126	0.00297	CcSEcCtD
Palonosetron—Pain—Dactinomycin—germ cell cancer	0.00126	0.00297	CcSEcCtD
Palonosetron—Body temperature increased—Bleomycin—germ cell cancer	0.00125	0.00294	CcSEcCtD
Palonosetron—Dizziness—Vinblastine—germ cell cancer	0.00124	0.00292	CcSEcCtD
Palonosetron—Convulsion—Cisplatin—germ cell cancer	0.00124	0.00291	CcSEcCtD
Palonosetron—CYP2D6—testis—germ cell cancer	0.00123	0.00435	CbGeAlD
Palonosetron—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00123	0.0029	CcSEcCtD
Palonosetron—Myalgia—Cisplatin—germ cell cancer	0.00122	0.00286	CcSEcCtD
Palonosetron—Paraesthesia—Ifosfamide—germ cell cancer	0.00121	0.00286	CcSEcCtD
Palonosetron—Anxiety—Cisplatin—germ cell cancer	0.00121	0.00285	CcSEcCtD
Palonosetron—Anaemia—Etoposide—germ cell cancer	0.00121	0.00285	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00121	0.00284	CcSEcCtD
Palonosetron—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00121	0.00284	CcSEcCtD
Palonosetron—Dyspnoea—Ifosfamide—germ cell cancer	0.0012	0.00284	CcSEcCtD
Palonosetron—Somnolence—Ifosfamide—germ cell cancer	0.0012	0.00283	CcSEcCtD
Palonosetron—Discomfort—Cisplatin—germ cell cancer	0.0012	0.00283	CcSEcCtD
Palonosetron—Vomiting—Vinblastine—germ cell cancer	0.00119	0.0028	CcSEcCtD
Palonosetron—Decreased appetite—Ifosfamide—germ cell cancer	0.00117	0.00277	CcSEcCtD
Palonosetron—Headache—Vinblastine—germ cell cancer	0.00117	0.00276	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00117	0.00275	CcSEcCtD
Palonosetron—Abdominal pain—Dactinomycin—germ cell cancer	0.00117	0.00275	CcSEcCtD
Palonosetron—Body temperature increased—Dactinomycin—germ cell cancer	0.00117	0.00275	CcSEcCtD
Palonosetron—Fatigue—Ifosfamide—germ cell cancer	0.00116	0.00274	CcSEcCtD
Palonosetron—Anaphylactic shock—Cisplatin—germ cell cancer	0.00116	0.00274	CcSEcCtD
Palonosetron—Hypersensitivity—Bleomycin—germ cell cancer	0.00116	0.00274	CcSEcCtD
Palonosetron—Infection—Cisplatin—germ cell cancer	0.00116	0.00273	CcSEcCtD
Palonosetron—Pain—Ifosfamide—germ cell cancer	0.00116	0.00272	CcSEcCtD
Palonosetron—Constipation—Ifosfamide—germ cell cancer	0.00116	0.00272	CcSEcCtD
Palonosetron—Nervous system disorder—Cisplatin—germ cell cancer	0.00114	0.00269	CcSEcCtD
Palonosetron—CYP2D6—cerebellum—germ cell cancer	0.00114	0.00402	CbGeAlD
Palonosetron—Tachycardia—Cisplatin—germ cell cancer	0.00114	0.00268	CcSEcCtD
Palonosetron—Asthenia—Bleomycin—germ cell cancer	0.00113	0.00267	CcSEcCtD
Palonosetron—Convulsion—Etoposide—germ cell cancer	0.00113	0.00267	CcSEcCtD
Palonosetron—Skin disorder—Cisplatin—germ cell cancer	0.00113	0.00267	CcSEcCtD
Palonosetron—Hypertension—Etoposide—germ cell cancer	0.00113	0.00266	CcSEcCtD
Palonosetron—Pruritus—Bleomycin—germ cell cancer	0.00112	0.00264	CcSEcCtD
Palonosetron—Nausea—Vinblastine—germ cell cancer	0.00111	0.00262	CcSEcCtD
Palonosetron—Anorexia—Cisplatin—germ cell cancer	0.00111	0.00262	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00111	0.0026	CcSEcCtD
Palonosetron—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.0011	0.0026	CcSEcCtD
Palonosetron—Discomfort—Etoposide—germ cell cancer	0.0011	0.00259	CcSEcCtD
Palonosetron—Hypotension—Cisplatin—germ cell cancer	0.00109	0.00256	CcSEcCtD
Palonosetron—Hypersensitivity—Dactinomycin—germ cell cancer	0.00109	0.00256	CcSEcCtD
Palonosetron—Abdominal pain—Ifosfamide—germ cell cancer	0.00107	0.00252	CcSEcCtD
Palonosetron—Body temperature increased—Ifosfamide—germ cell cancer	0.00107	0.00252	CcSEcCtD
Palonosetron—Anaphylactic shock—Etoposide—germ cell cancer	0.00107	0.00251	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00106	0.0025	CcSEcCtD
Palonosetron—Infection—Etoposide—germ cell cancer	0.00106	0.0025	CcSEcCtD
Palonosetron—Asthenia—Dactinomycin—germ cell cancer	0.00106	0.00249	CcSEcCtD
Palonosetron—Paraesthesia—Cisplatin—germ cell cancer	0.00105	0.00246	CcSEcCtD
Palonosetron—Tachycardia—Etoposide—germ cell cancer	0.00104	0.00245	CcSEcCtD
Palonosetron—Dyspnoea—Cisplatin—germ cell cancer	0.00104	0.00245	CcSEcCtD
Palonosetron—Skin disorder—Etoposide—germ cell cancer	0.00104	0.00244	CcSEcCtD
Palonosetron—Anorexia—Etoposide—germ cell cancer	0.00102	0.0024	CcSEcCtD
Palonosetron—Decreased appetite—Cisplatin—germ cell cancer	0.00101	0.00239	CcSEcCtD
Palonosetron—Diarrhoea—Dactinomycin—germ cell cancer	0.00101	0.00238	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00101	0.00237	CcSEcCtD
Palonosetron—Vomiting—Bleomycin—germ cell cancer	0.00101	0.00237	CcSEcCtD
Palonosetron—Hypotension—Etoposide—germ cell cancer	0.000997	0.00235	CcSEcCtD
Palonosetron—Rash—Bleomycin—germ cell cancer	0.000997	0.00235	CcSEcCtD
Palonosetron—Pain—Cisplatin—germ cell cancer	0.000996	0.00235	CcSEcCtD
Palonosetron—Dermatitis—Bleomycin—germ cell cancer	0.000996	0.00235	CcSEcCtD
Palonosetron—Hypersensitivity—Ifosfamide—germ cell cancer	0.000996	0.00235	CcSEcCtD
Palonosetron—Asthenia—Ifosfamide—germ cell cancer	0.000969	0.00228	CcSEcCtD
Palonosetron—Paraesthesia—Etoposide—germ cell cancer	0.000958	0.00226	CcSEcCtD
Palonosetron—Pruritus—Ifosfamide—germ cell cancer	0.000956	0.00225	CcSEcCtD
Palonosetron—Dyspnoea—Etoposide—germ cell cancer	0.000951	0.00224	CcSEcCtD
Palonosetron—Somnolence—Etoposide—germ cell cancer	0.000949	0.00224	CcSEcCtD
Palonosetron—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000948	0.00223	CcSEcCtD
Palonosetron—Epistaxis—Methotrexate—germ cell cancer	0.000945	0.00223	CcSEcCtD
Palonosetron—Nausea—Bleomycin—germ cell cancer	0.000939	0.00221	CcSEcCtD
Palonosetron—Vomiting—Dactinomycin—germ cell cancer	0.000938	0.00221	CcSEcCtD
Palonosetron—Rash—Dactinomycin—germ cell cancer	0.00093	0.00219	CcSEcCtD
Palonosetron—Decreased appetite—Etoposide—germ cell cancer	0.000928	0.00219	CcSEcCtD
Palonosetron—CYP2D6—brain—germ cell cancer	0.000925	0.00327	CbGeAlD
Palonosetron—Diarrhoea—Ifosfamide—germ cell cancer	0.000925	0.00218	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000921	0.00217	CcSEcCtD
Palonosetron—Body temperature increased—Cisplatin—germ cell cancer	0.000921	0.00217	CcSEcCtD
Palonosetron—Fatigue—Etoposide—germ cell cancer	0.00092	0.00217	CcSEcCtD
Palonosetron—Pain—Etoposide—germ cell cancer	0.000913	0.00215	CcSEcCtD
Palonosetron—Constipation—Etoposide—germ cell cancer	0.000913	0.00215	CcSEcCtD
Palonosetron—Dizziness—Ifosfamide—germ cell cancer	0.000894	0.0021	CcSEcCtD
Palonosetron—Urinary tract disorder—Methotrexate—germ cell cancer	0.000889	0.00209	CcSEcCtD
Palonosetron—Urethral disorder—Methotrexate—germ cell cancer	0.000882	0.00208	CcSEcCtD
Palonosetron—Nausea—Dactinomycin—germ cell cancer	0.000876	0.00206	CcSEcCtD
Palonosetron—Gastrointestinal pain—Etoposide—germ cell cancer	0.000873	0.00206	CcSEcCtD
Palonosetron—Vomiting—Ifosfamide—germ cell cancer	0.000859	0.00202	CcSEcCtD
Palonosetron—Hypersensitivity—Cisplatin—germ cell cancer	0.000858	0.00202	CcSEcCtD
Palonosetron—Rash—Ifosfamide—germ cell cancer	0.000852	0.00201	CcSEcCtD
Palonosetron—Dermatitis—Ifosfamide—germ cell cancer	0.000851	0.00201	CcSEcCtD
Palonosetron—Abdominal pain—Etoposide—germ cell cancer	0.000844	0.00199	CcSEcCtD
Palonosetron—Body temperature increased—Etoposide—germ cell cancer	0.000844	0.00199	CcSEcCtD
Palonosetron—Eye disorder—Methotrexate—germ cell cancer	0.000841	0.00198	CcSEcCtD
Palonosetron—Tinnitus—Methotrexate—germ cell cancer	0.000839	0.00198	CcSEcCtD
Palonosetron—Asthenia—Cisplatin—germ cell cancer	0.000836	0.00197	CcSEcCtD
Palonosetron—Cardiac disorder—Methotrexate—germ cell cancer	0.000835	0.00197	CcSEcCtD
Palonosetron—Angiopathy—Methotrexate—germ cell cancer	0.000816	0.00192	CcSEcCtD
Palonosetron—Immune system disorder—Methotrexate—germ cell cancer	0.000813	0.00191	CcSEcCtD
Palonosetron—Mediastinal disorder—Methotrexate—germ cell cancer	0.000811	0.00191	CcSEcCtD
Palonosetron—Chills—Methotrexate—germ cell cancer	0.000807	0.0019	CcSEcCtD
Palonosetron—Nausea—Ifosfamide—germ cell cancer	0.000803	0.00189	CcSEcCtD
Palonosetron—Diarrhoea—Cisplatin—germ cell cancer	0.000797	0.00188	CcSEcCtD
Palonosetron—Alopecia—Methotrexate—germ cell cancer	0.000795	0.00187	CcSEcCtD
Palonosetron—Mental disorder—Methotrexate—germ cell cancer	0.000788	0.00186	CcSEcCtD
Palonosetron—Hypersensitivity—Etoposide—germ cell cancer	0.000786	0.00185	CcSEcCtD
Palonosetron—Malnutrition—Methotrexate—germ cell cancer	0.000783	0.00185	CcSEcCtD
Palonosetron—Erythema—Methotrexate—germ cell cancer	0.000783	0.00185	CcSEcCtD
Palonosetron—Dysgeusia—Methotrexate—germ cell cancer	0.000767	0.00181	CcSEcCtD
Palonosetron—Asthenia—Etoposide—germ cell cancer	0.000766	0.0018	CcSEcCtD
Palonosetron—Pruritus—Etoposide—germ cell cancer	0.000755	0.00178	CcSEcCtD
Palonosetron—Vomiting—Cisplatin—germ cell cancer	0.000741	0.00174	CcSEcCtD
Palonosetron—Rash—Cisplatin—germ cell cancer	0.000735	0.00173	CcSEcCtD
Palonosetron—Dermatitis—Cisplatin—germ cell cancer	0.000734	0.00173	CcSEcCtD
Palonosetron—Diarrhoea—Etoposide—germ cell cancer	0.00073	0.00172	CcSEcCtD
Palonosetron—Anaemia—Methotrexate—germ cell cancer	0.000724	0.00171	CcSEcCtD
Palonosetron—Dizziness—Etoposide—germ cell cancer	0.000706	0.00166	CcSEcCtD
Palonosetron—Nausea—Cisplatin—germ cell cancer	0.000692	0.00163	CcSEcCtD
Palonosetron—Convulsion—Methotrexate—germ cell cancer	0.000679	0.0016	CcSEcCtD
Palonosetron—Vomiting—Etoposide—germ cell cancer	0.000679	0.0016	CcSEcCtD
Palonosetron—Rash—Etoposide—germ cell cancer	0.000673	0.00159	CcSEcCtD
Palonosetron—Dermatitis—Etoposide—germ cell cancer	0.000672	0.00158	CcSEcCtD
Palonosetron—Headache—Etoposide—germ cell cancer	0.000669	0.00157	CcSEcCtD
Palonosetron—Arthralgia—Methotrexate—germ cell cancer	0.000667	0.00157	CcSEcCtD
Palonosetron—Myalgia—Methotrexate—germ cell cancer	0.000667	0.00157	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000662	0.00156	CcSEcCtD
Palonosetron—Discomfort—Methotrexate—germ cell cancer	0.000659	0.00155	CcSEcCtD
Palonosetron—Anaphylactic shock—Methotrexate—germ cell cancer	0.000639	0.00151	CcSEcCtD
Palonosetron—Infection—Methotrexate—germ cell cancer	0.000635	0.0015	CcSEcCtD
Palonosetron—Nausea—Etoposide—germ cell cancer	0.000634	0.00149	CcSEcCtD
Palonosetron—Nervous system disorder—Methotrexate—germ cell cancer	0.000627	0.00148	CcSEcCtD
Palonosetron—Skin disorder—Methotrexate—germ cell cancer	0.000621	0.00146	CcSEcCtD
Palonosetron—Anorexia—Methotrexate—germ cell cancer	0.000609	0.00144	CcSEcCtD
Palonosetron—Hypotension—Methotrexate—germ cell cancer	0.000597	0.00141	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000582	0.00137	CcSEcCtD
Palonosetron—Insomnia—Methotrexate—germ cell cancer	0.000578	0.00136	CcSEcCtD
Palonosetron—Paraesthesia—Methotrexate—germ cell cancer	0.000574	0.00135	CcSEcCtD
Palonosetron—Dyspnoea—Methotrexate—germ cell cancer	0.00057	0.00134	CcSEcCtD
Palonosetron—Somnolence—Methotrexate—germ cell cancer	0.000568	0.00134	CcSEcCtD
Palonosetron—Dyspepsia—Methotrexate—germ cell cancer	0.000563	0.00133	CcSEcCtD
Palonosetron—Decreased appetite—Methotrexate—germ cell cancer	0.000556	0.00131	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000552	0.0013	CcSEcCtD
Palonosetron—Fatigue—Methotrexate—germ cell cancer	0.000551	0.0013	CcSEcCtD
Palonosetron—Pain—Methotrexate—germ cell cancer	0.000547	0.00129	CcSEcCtD
Palonosetron—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000523	0.00123	CcSEcCtD
Palonosetron—Body temperature increased—Methotrexate—germ cell cancer	0.000505	0.00119	CcSEcCtD
Palonosetron—Abdominal pain—Methotrexate—germ cell cancer	0.000505	0.00119	CcSEcCtD
Palonosetron—Hypersensitivity—Methotrexate—germ cell cancer	0.000471	0.00111	CcSEcCtD
Palonosetron—Asthenia—Methotrexate—germ cell cancer	0.000459	0.00108	CcSEcCtD
Palonosetron—Pruritus—Methotrexate—germ cell cancer	0.000452	0.00107	CcSEcCtD
Palonosetron—Diarrhoea—Methotrexate—germ cell cancer	0.000437	0.00103	CcSEcCtD
Palonosetron—Dizziness—Methotrexate—germ cell cancer	0.000423	0.000996	CcSEcCtD
Palonosetron—Vomiting—Methotrexate—germ cell cancer	0.000406	0.000957	CcSEcCtD
Palonosetron—Rash—Methotrexate—germ cell cancer	0.000403	0.000949	CcSEcCtD
Palonosetron—Dermatitis—Methotrexate—germ cell cancer	0.000403	0.000949	CcSEcCtD
Palonosetron—Headache—Methotrexate—germ cell cancer	0.0004	0.000943	CcSEcCtD
Palonosetron—Nausea—Methotrexate—germ cell cancer	0.00038	0.000894	CcSEcCtD
